DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

CORONA Remedies Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·22 Jul 2026, 9:06 am

Corona Remedies

Corona Remedies Limited has announced that it will host a meeting with analysts and institutional investors. This event is scheduled for the upcoming month and will focus on the company's financial performance and future outlook.

For investors, such meetings are significant as they provide an opportunity for the company to communicate directly with the market. It allows management to share insights into their business strategy and address any queries from the investment community, which can help in building a clearer picture of the company's trajectory.

Investors should watch for any specific guidance or updates regarding the company's growth plans, financial targets, or sector performance that may be shared during the discussion.